|Title||Public Library of Science (PLOS)|
Professional Publisher (Large)
|Owner||PLOS (Public Library of Science) is a nonprofit publisher and advocacy organization with a mission of leading a transformation in scientific and medical research communication. It is a tax-exempt, 501(c)3, nonprofit corporation headquartered in San Francisco, California.|
|Address||Public Library of Science (PLOS)
1160 Battery Street, Koshland Building East, Suite 225
San Francisco, CA 94111, USA
|Copyright and Licensing||http://www.plos.org/about/open-access/license/|
|Copyright and Licensing Policy||The Public Library of Science (PLOS) applies the Creative Commons Attribution License (CC-BY) to works we publish (read the human-readable summary or the full license legal code). Under this license, authors retain ownership of the copyright for their content, but allow anyone to download, reuse, reprint, modify, distribute, and/or copy the content as long as the original authors and source are cited. No permission is required from the authors or the .|
|Complaint firstname.lastname@example.org, or per journal|
|Complaint policy||>For Example, for PLOS Biology: Appeals of DecisionsIf you wish to appeal a decision, you should contact the professional editor who handled the presubmission inquiry or full manuscript, explaining in detail your reasons for the appeal. Appeals will only be considered when a reviewer or editor is thought to have made a significant factual error or when his/her objectivity is compromised by a documented competing interest, and when a reversal based on either of these grounds would change the original decision.All appeals will be discussed with at least one other professional editor; if those editors do not agree the appeal will be discussed at a full editorial meeting. Priority is given to new submissions to the journal, and the processing of appeals will usually take longer than the original submission. We hope, however, that this will not take longer than two weeks. While under appeal, a manuscript remains under formal consideration at PLOS Biology and hence should not be submitted for consideration elsewhere. We may or may not seek external advice on appeals, and we do not consider second appeals.|
|Publication charge link||http://www.plos.org/publish/pricing-policy/publication-fees/|
|Publication charge policy||PLOS is committed to the widest possible global participation in open access publishing. To determine the appropriate fee, we use a country-based pricing model, which is based on the country that provides 50% or more of the primary funding for the research that is being submitted. Research articles funded by Upper Middle and High Income Countries incur our standard publication fees. Corresponding authors who are affiliated with one of our Institutional Members are eligible for a discount on this fee. Such authors will be informed of the discount applicable after submission of their manuscript.Fees for Low and Lower Middle Income Countries are calculated according to the PLOS Global Participation Initiative for manuscripts submitted after 9am Pacific Time on September 4, 2012 (this program is not retroactive).|
|OASPA Compliant OA Journals||7 (PLOS ONE, PLOS Genetics, PLOS Computational Biology, PLOS Pathogens, PLOS Neglected Tropical Diseases, PLOS Medicine, PLOS Biology)|
approx. number in 12 months
|34,824 (In 2013)|
|Initiatives||PLOS Currents is an innovative, online publication channel for new scientific research and ideas organized by focused research areas. It aims to minimize the delay between the generation and publication of new research and publishes content that is peer-reviewed; citable; publicly archived in PubMed; and indexed by Scopus.|
|Peer review policy||For PLOS ONE: http://www.plosone.org/static/information
The peer review process does not judge the importance of the work, rather focuses on whether the work is done to high scientific and ethical standards and is appropriately described, and that the data support the conclusions.
For other PLOS Journals:
See for example PLOS Biology http://www.plosbiology.org/static/guidelines
Our aim is to provide all authors with an efficient, courteous, and constructive editorial process. To ensure the fairest and most objective decision-making, the editorial process is run as a partnership between the PLOS Biology professional editors and the Editorial Board, which is comprised of leaders in all fields of biology.
The ultimate responsibility for the PLOS Biology content and editorial decision-making lies with the team of professional editors.
See for example PLOS Genetics http://www.plosgenetics.org/static/guidelines
Our aim is to provide all authors with an efficient, courteous, and constructive editorial process. To achieve its required level of quality, PLOS Genetics is highly selective in the manuscripts that it publishes; rejection rates are high. To ensure the fairest and most objective decision-making, the editorial process is run as a partnership between the PLOS Genetics Editor-in-Chief, a Deputy Editor, a team of Section Editors (SEs), and a group of academic experts who act as Associate Editors (AEs). These individuals are leaders in their fields and represent the full breadth of genetics and genomics.
Submitted manuscripts are first reviewed by the EIC, Deputy Editor, or one of the SEs, who may decide to reject the paper or send it on to an AE for further review. The AE is most often a member of the PLOS Genetics Editorial Board, but occasionally a guest of the Board is invited to serve in this capacity. The AE evaluates the paper and decides whether it describes a sufficient body of work to support a major advance in a particular field. If so, the paper is sent out for external peer review, at which stage the technical and scientific merits of the work are carefully considered. Once the reviews have been received and considered by the editors, a decision letter to the corresponding author is drafted and sent.